This article was originally published in The Gray Sheet
Firm's IntraStent DoubleStrut biliary endoprosthesis gains 510(k) clearance for treatment of peripheral and non-vascular obstructive disease. The balloon-expandable stent combines "flexibility, lumen coverage and radial strength" without compromising performance, the firm maintains. Available in 16, 26, 36, 56, and 76-mm lengths and diameters expandable from 5-10 mm, the IntraStent DoubleStrut is also being studied in clinical trials for an iliac indication
You may also be interested in...
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.